An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...

Forty-two years after approving the potent diuretic Bumex (bumetanide) as both an oral and infused treatment for edema, the FDA has endorsed a new version of the drug to be delivered as a nasal spray.

GDDs significantly increase corneal edema risk compared to trabeculectomy, with a 27.7% incidence versus 13.5% for trabeculectomy. MIGS and Xen stents show lower risks for corneal edema, with ...